Literature DB >> 14568246

Immunosuppressive therapy in liver transplantation.

Filomena Conti1, Emmanuel Morelon, Yvon Calmus.   

Abstract

Mesh：

Year:  2003        PMID： 14568246     DOI： 10.1016/s0168-8278(03)00428-8

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  4 in total

Review 1.  Surgical management of hepatocellular carcinoma.

Authors:  Tony Cy Pang; Vincent Wt Lam
Journal:  World J Hepatol       Date:  2015-02-27

2.  A network meta-analysis of the efficacy and side effects of UDCA-based therapies for primary sclerosing cholangitis.

Authors:  Gui-Qi Zhu; Ke-Qing Shi; Gui-Qian Huang; Li-Ren Wang; Yi-Qian Lin; Martin Braddock; Yong-Ping Chen; Meng-Tao Zhou; Ming-Hua Zheng
Journal:  Oncotarget       Date:  2015-09-29

Review 3.  Natural killer cells in liver transplantation: Can we harness the power of the immune checkpoint to promote tolerance?

Authors:  Jennifer Halma; Stephen Pierce; Rebecca McLennan; Todd Bradley; Ryan Fischer
Journal:  Clin Transl Sci       Date:  2021-12-15       Impact factor: 4.438

4.  Early introduction of everolimus immunosuppressive regimen in liver transplantation with extra-anatomic aortoiliac-hepatic arterial graft anastomosis.

Authors:  Emanuele Felli; Giovanni Vennarecci; Marco Colasanti; Roberto Santoro; Edoardo de Werra; Andrea Scotti; Mirco Burocchi; Giovanni B Levi Sandri; Alessandra Campanelli; Pasquale Lepiane; Giuseppe M Ettorre
Journal:  Case Rep Transplant       Date:  2014-09-21
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.